Business Context and Reporting Period
Company: Bristol-Myers Squibb Company
Filing Type: Form 8-K (Current Report)
Report Date: October 29, 2004
Reporting Period: Third Quarter of 2004
Context: This filing serves to announce the company's financial results for the third quarter of 2004. The detailed results are contained in a press release (Exhibit 99.1) and supplemental information (Exhibit 99.2) incorporated by reference.
Key Financial Metrics
The provided text is a cover sheet and index for the Form 8-K. It references the existence of financial results but does not contain the specific numerical data. Consequently, the following metrics are not available in this text:
- Revenue: Not provided in filing text.
- Profit: Not provided in filing text.
- Cash Flow: Not provided in filing text.
- Margins: Not provided in filing text.
- Debt and Liquidity: Not provided in filing text.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. Investors must refer to the incorporated press release (Exhibit 99.1) for year-over-year comparisons.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. These disclosures are located within the referenced exhibits.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q3 2004 revenue, net income, and earnings per share figures.
- Examine Exhibit 99.2 for supplemental data not included in the main press release.
- Verify the company's forward-looking statements and guidance for the full year 2004 within the press release.
- Check for any specific product performance updates or litigation contingencies mentioned in the full report.